CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Phynova Group Plc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Phynova Group Plc
16 Blenheim Office Park Long Hanborough
Phone: 01993 880 700p:01993 880 700 Oxfordshire, 0X29 8LN  United Kingdom Ticker: PYNPYN

This company is no longer actively traded on any major stock exchange.

Business Summary
Phynova Group plc is a developer of pharmaceuticals for therapeutic needs, such as metabolic syndrome, hepatitis C and MRSA. Its drugs comprise pharmacologically active polymolecular mixtures derived from medicinal plants that have a history of use as medicines in countries like China. It operates through its subsidiaries, which include Phynova Limited, which is engaged in drug development, and Phynova China Limited, which is a holding company. The Company has operations in China. The Companies products include PYN17, PYN22, PYN9-BCCL, PYN6, PYN18, and PYN7. The Company developed products, which are used as ingredients for the nutraceutical and cosmetic industries.
(Source: ARS)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20099/30/2008Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Non-Executive Chairman of the Board Ralph S.Harris 67 6/5/2009 9/19/2008
Chief Executive Officer, Director RobertMiller 55 6/5/2009 8/11/2004
Part-Time Chief Financial Officer, Secretary, Director MichaelMartin 6/5/2009 8/11/2004
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Phynova China Limited
Phynova Group plc
Phynova Limited
PYN

General Information
Number of Employees: 6 (As of 9/30/2008)
Outstanding Shares: 31,716,726 (As of 6/30/2009)
Stock Exchange: SEA
Fax Number: 01993 886 687


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023